Fully implantable brain–computer interface development heading toward longer-term human studies is profiled here. Discover its technology goals, clinical ambitions and collaborative roadmap.
Key Takeaways
- Find everything from accelerators to investors and meet like-minded people in thestartup community
- Geneva-based company has received Investigational Medical Device Dossier (IMDD)
- Company was spun out of Wyss Center for Bio and Neuroengineering in Geneva in 2025